Lombardi Comprehensive Cancer Center, Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Lombardi Comprehensive Cancer Center, Georgetown University has participated in 14 clinical trials with 6 currently active.
Therapeutic areas: Cancer, Multiple Myeloma, Colorectal Neoplasms.
Sponsors: Advanced Cancer Therapeutics, Hackensack Meridian Health, Dynavax Technologies Corporation.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lombardi Comprehensive Cancer Center, Georgetown University has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lombardi Comprehensive Cancer Center, Georgetown University has 14 clinical trials on record, with 6 currently active. Their work covers Cancer, Multiple Myeloma, Colorectal Neoplasms.
Yes — Lombardi Comprehensive Cancer Center, Georgetown University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.